Role of computed tomography in predicting critical disease in patients with covid-19 pneumonia: A retrospective study using a semiautomatic quantitative method

Andrea Leonardi, Roberto Scipione, Giulia Alfieri, Roberta Petrillo, Miriam Dolciami, Fabio Ciccarelli, Stefano Perotti, Gaia Cartocci, Annarita Scala, Carmela Imperiale, Franco Iafrate, Marco Francone, Carlo Catalano, Paolo Ricci, Andrea Leonardi, Roberto Scipione, Giulia Alfieri, Roberta Petrillo, Miriam Dolciami, Fabio Ciccarelli, Stefano Perotti, Gaia Cartocci, Annarita Scala, Carmela Imperiale, Franco Iafrate, Marco Francone, Carlo Catalano, Paolo Ricci

Abstract

Background: So far, only a few studies evaluated the correlation between CT features and clinical outcome in patients with COVID-19 pneumonia.

Purpose: To evaluate CT ability in differentiating critically ill patients requiring invasive ventilation from patients with less severe disease.

Methods: We retrospectively collected data from patients admitted to our institution for COVID-19 pneumonia between March 5th-24th. Patients were considered critically ill or non-critically ill, depending on the need for mechanical ventilation. CT images from both groups were analyzed for the assessment of qualitative features and disease extension, using a quantitative semiautomatic method. We evaluated the differences between the two groups for clinical, laboratory and CT data. Analyses were conducted on a per-protocol basis.

Results: 189 patients were analyzed. PaO2/FIO2 ratio and oxygen saturation (SaO2) were decreased in critically ill patients. At CT, mixed pattern (ground glass opacities (GGO) and consolidation) and GGO alone were more frequent respectively in critically ill and in non-critically ill patients (p < 0.05). Lung volume involvement was significantly higher in critically ill patients (38.5 % vs. 5.8 %, p < 0.05). A cut-off of 23.0 % of lung involvement showed 96 % sensitivity and 96 % specificity in distinguishing critically ill patients from patients with less severe disease. The fraction of involved lung was related to lactate dehydrogenase (LDH) levels, PaO2/FIO2 ratio and SaO2 (p < 0.05).

Conclusion: Lung disease extension, assessed using quantitative CT, has a significant relationship with clinical severity and may predict the need for invasive ventilation in patients with COVID-19.

Keywords: COVID-19; Invasive mechanical ventilation; Lung volume; Pneumonia; Quantitative CT; SARS- CoV-2.

Copyright © 2020 Elsevier B.V. All rights reserved.

Figures

Fig. 1
Fig. 1
CT quantitative assessment of disease extension in a non-critically ill Patient with SARS-CoV-2 pneumonia. (A-C) CT image viewed at lung window, on the axial plane. On the same slice, the operator manually drew the contour of the left lower lobe (red line) and the portion of involved parenchyma in it (yellow line). The final volume was automatically computed and measured afterwards. (D,E) Volumetric representation of lung involvement (Vitrea software, version 7.10.1.20), with frontal and lateral view.
Fig. 2
Fig. 2
CT quantitative assessment of disease extension in a critically ill Patient with SARS-CoV-2 pneumonia. (A-C) CT image viewed at lung window, on the axial plane. On the same slice, the operator manually drew the contour of the left superior lobe (red line) and the portion of involved parenchyma in it (yellow line). The final volume was automatically computed and measured afterwards. (D,E) Volumetric representation of lung involvement (Vitrea software, version 7.10.1.20), with frontal and lateral view.
Fig. 3
Fig. 3
ROC curve analysis evaluating the differential diagnosis ability of quantitative CT in critically ill and non-critically ill patients. The area under the curve (AUC) of affected lung (%) for diagnosing critically ill disease was 0.982 (95 %CI 0.953–1.000). The cut-off of 23.0 % had 96 % sensitivity and 96 % specificity.

References

    1. 2020. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 -. 11 March 2020. (accessed 5 April 2020)
    1. Thomas-Rüddel D., Winning J., Dickmann P. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist. 2020:1–10. doi: 10.1007/s00101-020-00758-x.
    1. Wu Z., McGoogan J.M., J. M Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020 doi: 10.1001/jama.2020.2648.
    1. Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Resp Med. 2020 doi: 10.1016/S2213-2600(20)30079-5.
    1. Guan W.J., Ni Z.Y., Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2002032.
    1. Ruan Q., Yang K., Wang W. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020:1–3. doi: 10.1007/s00134-020-05991-x.
    1. Cao J., Hu X., Cheng W., Yu L. Clinical features and short-term outcomes of 18 patients with coronavirus disease 2019 in intensive care unit. Intensive Care Med. 2020:1–3. doi: 10.1007/s00134-020-05987-7.
    1. ESICM Webinar. Of Intensive Care Medicine. 2020. Medicine ESOIC, ESICM webinar—update on coronavirus.
    1. Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5.
    1. Wang D., Hu B., Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585.
    1. Zhou F., Yu T., Du R. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
    1. Meng L., Qiu H., Wan L. Intubation and ventilation amid the COVID-19 outbreak: wuhan’s experience. Anesthesiology. 2020 doi: 10.1097/ALN.0000000000003296.
    1. Ai T., Yang Z., Hou H. Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 2020:200642. doi: 10.1148/radiol.2020200642.
    1. Bernheim A., Mei X., Huang M. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020:200463. doi: 10.1148/radiol.2020200463.
    1. Kim H., Hong H., Yoon S.H. Diagnostic performance of CT and reverse transcriptase-polymerase chain reaction for coronavirus disease 2019: a meta-analysis. Radiology. 2020:201343. doi: 10.1148/radiol.2020201343.
    1. Zhao W., Zhong Z., X Xie. Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study. AJR Am. J. Roentgenol. 2020:1–6. doi: 10.2214/AJR.20.22976.
    1. Li K., Fang Y., Li W. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19) Eur. Radiol. 2020:1–10. doi: 10.1007/s00330-020-06817-6.
    1. Colombi D., Bodini F.C., Petrini M., Maffi G., Morelli N., Milanese G., Michieletti E. Well-aerated lung on admitting chest CT to predict adverse outcome in COVID-19 pneumonia. Radiology. 2020:201433. doi: 10.1148/radiol.2020201433.
    1. 7th ed. 2020. China National Health Commission, Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment. (Accessed April 14 2020)
    1. Guan W.J., Liang W.H., Zhao Y. Comorbidity and its impact on 1590 patients with Covid-19 in China: a Nationwide Analysis. Eur. Respir. J. 2020 doi: 10.1183/13993003.00547-2020.
    1. Danzi G.B., Loffi M., Galeazzi G. Acute pulmonary embolism and COVID-19 pneumonia: a random association? Eur. Heart J. 2020 doi: 10.1093/eurheartj/ehaa254.
    1. Rotzinger D.C., Beigelman-Aubry C., von Garnier C., Qanadli S.D. Pulmonary embolism in patients with COVID-19: time to change the paradigm of computed tomography. Thromb. Res. 2020 doi: 10.1016/j.thromres.2020.04.011.
    1. Broccard A.F. Making sense of the pressure of arterial oxygen to fractional inspired oxygen concentration ratio in patients with acute respiratory distress syndrome. OA Crit Care. 2013;1:1.
    1. Shi H., Han X., Zheng C. Evolution of CT manifestations in a patient recovered from 2019 novel coronavirus (2019-nCoV) pneumonia in Wuhan, China. Radiology. 2020;295 doi: 10.1148/radiol.2020200269. 20-20.
    1. Ding X., Xu J., Zhou J., Long Q. Chest CT findings of COVID-19 pneumonia by duration of symptoms. Eur. J. Radiol. 2020;109009 doi: 10.1016/j.ejrad.2020.109009.
    1. Yang Q., Liu Q., Xu H., Lu H., Liu S., Li H. Imaging of coronavirus disease 2019: a Chinese expert consensus statement. Eur. J. Radiol. 2020:109008. doi: 10.1016/j.ejrad.2020.109008.
    1. Caruso D., Zerunian M., Polici M. Chest CT Features of COVID-19 in Rome, Italy. Radiology. 2020;2020:201237. doi: 10.1148/radiol.2020201237.
    1. Shi Y., Wang Y., Shao C. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020 doi: 10.1038/s41418-020-0530-3.
    1. Ooi G.C., Khong P.L., Müller N.L. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004;230(3):836–844. doi: 10.1148/radiol.2303030853.
    1. Xie J., Tong Z., Guan X. 2020. Critical Care Crisis and Some Recommendations During the COVID-19 Epidemic in China. Intensive Care Medicine; pp. 1–4.
    1. Gattinoni L., Chiumello D., Caironi P. COVID-19 pneumonia: different respiratory treatment for different phenotypes? Intensive Care Med. 2020 doi: 10.1007/s00134-020-06033-2.

Source: PubMed

3
Abonnere